2.84
Precedente Chiudi:
$2.62
Aprire:
$3.14
Volume 24 ore:
9.75M
Relative Volume:
5.27
Capitalizzazione di mercato:
$279.40M
Reddito:
$361.07M
Utile/perdita netta:
$-71.54M
Rapporto P/E:
-3.5949
EPS:
-0.79
Flusso di cassa netto:
$-47.97M
1 W Prestazione:
+2.16%
1M Prestazione:
+13.15%
6M Prestazione:
-6.89%
1 anno Prestazione:
+336.99%
Oncology Institute Inc Stock (TOI) Company Profile
Nome
Oncology Institute Inc
Settore
Industria
Telefono
562-735-3226
Indirizzo
18000 STUDEBAKER RD, CERRITOS
Compare TOI vs HCA, THC, FMS, ENSG, UHS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TOI
Oncology Institute Inc
|
2.84 | 279.40M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
532.97 | 119.18B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
227.63 | 19.80B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.79 | 12.73B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
209.71 | 12.19B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
192.42 | 11.75B | 17.36B | 1.51B | 849.25M | 23.15 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Iniziato | Needham | Buy |
| 2025-07-23 | Iniziato | Noble Capital Markets | Outperform |
| 2025-07-16 | Iniziato | B. Riley Securities | Buy |
| 2025-05-15 | Iniziato | BTIG Research | Buy |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2022-09-14 | Iniziato | Guggenheim | Buy |
| 2022-08-15 | Iniziato | Jefferies | Buy |
Mostra tutto
Oncology Institute Inc Borsa (TOI) Ultime notizie
B. Riley’s Price Target Boost Signals Growth for Oncology Institute - StocksToTrade
Oncology Institute (TOI) Q4 Loss Per Share Improvement Tests Longstanding Profitability Doubts - simplywall.st
Oncology Institute Updates Investors With New Presentation - TipRanks
The Oncology Institute (NASDAQ: TOI) furnishes updated investor presentation - Stock Titan
Oncology Institute’s Q4 Surprises Stir Investor Interest - StocksToTrade
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... By GuruFocus - Investing.com Canada
Oncology Institute Q4 Earnings Call Highlights - Yahoo Finance
The Oncology Institute: Value-Based Cancer Care Model, Growth Strategy, and Market Expansion Overview 32 - Minichart
Earnings call transcript: Oncology Institute Q4 2025 beats EPS estimates, stock rises - Investing.com
Oncology Institute 2025 10-K: $502.7M Revenue, $(0.54) EPS - TradingView
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026 - The Manila Times
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance ... - Bluefield Daily Telegraph
Cancer clinic network aims for positive adjusted EBITDA in 2026 - Stock Titan
Oncology Institute Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
TOI: BTIG Reiterates Buy Rating, Maintains $7 Price Target | TOI Stock News - GuruFocus
Oncology Institute (NASDAQ:TOI) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Oncology Institute's (TOI) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Oncology Institute (TOI) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Aug Momentum: Should you avoid The Oncology Institute Inc stock right now2025 Buyback Activity & Real-Time Buy Zone Alerts - baoquankhu1.vn
Risk Report: What is The Oncology Institute Inc Equity Warrants revenue forecastVolume Spike & Expert Verified Movement Alerts - baoquankhu1.vn
Risk Report: What analysts say about The Oncology Institute Inc stockEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Street Watch: What are the risks of holding The Oncology Institute Inc Equity WarrantJuly 2025 Selloffs & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - The Manila Times
Comparing Sera Prognostics (NASDAQ:SERA) & Oncology Institute (NASDAQ:TOI) - Defense World
The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call - The Manila Times
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March - The Manila Times
Risk Report: What is The Oncology Institute Inc Equity Warrants market position2025 Trade Ideas & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Decliners: Is The Oncology Institute Inc impacted by rising ratesEarnings Growth Report & Safe Entry Point Identification - baoquankhu1.vn
The Oncology Institute appoints Kim Tzoumakas to board By Investing.com - Investing.com India
The Oncology Institute appoints Kim Tzoumakas to board - Investing.com Australia
Oncology Institute Adds Independent Director to Board - TipRanks
Kim Tzoumakas joins The Oncology Institute (NASDAQ: TOI) board - Stock Titan
Buyout Rumor: Is The Oncology Institute Inc impacted by rising ratesQuarterly Trade Summary & AI Driven Stock Reports - baoquankhu1.vn
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors - Bitget
Does The Oncology Institute Inc. Equity Warrant have pricing powerJuly 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Is The Oncology Institute Inc. forming a bullish divergenceJuly 2025 PreEarnings & Low Risk High Win Rate Picks - mfd.ru
CEO Change: Why is The Oncology Institute Inc. stock going upJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - mfd.ru
How The Oncology Institute Inc. stock reacts to global recession fears2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - mfd.ru
MSN Money - MSN
Is The Oncology Institute Inc. Equity Warrant stock supported by strong fundamentals2025 Performance Recap & Low Risk Growth Stock Ideas - mfd.ru
Is The Oncology Institute Inc. Equity Warrant a potential multi baggerPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - mfd.ru
History Review: Should you avoid The Oncology Institute Inc Equity Warrant stock right nowLong Setup & Daily Momentum Trading Reports - baoquankhu1.vn
Is The Oncology Institute Inc. Equity Warrant’s ROE strong enoughCPI Data & Fast Entry Momentum Trade Alerts - mfd.ru
Risk Report: Is MGRC attractive at current valuation2025 Retail Activity & AI Driven Stock Reports - baoquankhu1.vn
Valuation Update: Can The Oncology Institute Inc continue delivering strong returns2025 Pullback Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Dividend Watch: Can The Oncology Institute Inc beat the S P 500Weekly Stock Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
CenterBook Partners LP Increases Stock Holdings in The Oncology Institute, Inc. $TOI - MarketBeat
Bull Run: Does ELPW have high return on assets2025 Key Highlights & Safe Entry Zone Identification - baoquankhu1.vn
Why is The Oncology Institute Inc. stock going upWeekly Investment Report & Scalable Portfolio Growth Methods - mfd.ru
Aug Ideas: Can The Oncology Institute Inc benefit from deglobalizationJuly 2025 Momentum & Breakout Confirmation Trade Signals - baoquankhu1.vn
Oncology Institute Inc Azioni (TOI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):